Frontiers in Pharmacology (Apr 2024)

Xie Zhuo Tiao Zhi formula ameliorates chronic alcohol-induced liver injury in mice

  • Kaixin Chang,
  • Rui Guo,
  • Wenbo Hu,
  • Xuezhu Wang,
  • Feiwei Cao,
  • Jiannan Qiu,
  • Jiaomei Li,
  • Qiang Han,
  • Zhongyan Du,
  • Xiaobing Dou,
  • Songtao Li

DOI
https://doi.org/10.3389/fphar.2024.1363131
Journal volume & issue
Vol. 15

Abstract

Read online

This study aimed to evaluate the protective role and potential mechanisms of Xie Zhuo Tiao Zhi decoction (XZTZ) on alcohol-associated liver disease (ALD). XZTZ significantly alleviated alcohol-induced liver dysfunction, based on histological examinations and biochemical parameters after 4-week administration. Mechanically, alcohol-stimulated hepatic oxidative stress was ameliorated by XZTZ, accompanied by the improvement of Nrf2/Keap1 expression and alcohol-activated phosphorylation of pro-inflammatory transcription factors, including JNK, P38, P65, and IκBα, were rescued by XZTZ. In conclusion, XZTZ demonstrates potential in alleviating alcohol-induced liver injury, oxidative stress, and inflammation possibly through modulation of Nrf2/Keap1 and MAPKs/NF-κB signaling pathways, suggesting its potential as a therapeutic option for patients with alcoholic liver disease.

Keywords